Federated Hermes, Inc. Syros Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.69 - $1.21 $1,226 - $2,150	-1,777 Reduced 0.74%	238,462 $230,000
Q1 2022 May 13, 2022	BUY	$1.02 - $3.8 $76,821 - $286,197	75,315 Added 45.67%	240,239 $286,000
Q4 2021 Feb 14, 2022	BUY	$3.26 - $4.66 $537,652 - $768,545	164,924 New	164,924 $538,000
Q4 2020 Feb 12, 2021	SELL	$6.66 - $14.66 $313,346 - $689,738	-47,049 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$8.69 - $14.47 $408,855 - $680,799	47,049 New	47,049 $416,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.